Follow
Subscribe to Gerresheimer AG
Filter
  • 12.10.2021 – 07:00

    Gerresheimer on growth course

    Duesseldorf (ots) - - Core business revenue shows third-quarter organic growth of 9.8 % - Strategic positioning as innovative provider of biotech, pharma and beauty solutions delivers results - Adjusted EBITDA margin in core business organically at 20.9 % in third quarter - Third-quarter adjusted earnings per share rise organically by 5.2 % - Guidance confirmed for the financial year 2021 Gerresheimer AG ...

    One document
  • 13.07.2021 – 07:00

    Gerresheimer accelerates revenue growth

    Düsseldorf (ots) - - Organic Group revenue growth of 7.5 %, and 7.1 % in core business - Solutions for biotech drugs and high-value solutions continue to drive revenues increase - Organic adjusted EBITDA margin at 22.8 % in core business - Adjusted earnings per share up organically by 19.1 % to EUR 1.28 - Guidance confirmed for the financial year 2021 ...

    One document
  • 08.04.2021 – 08:52

    Gerresheimer with positive start to the financial year 2021

    Duesseldorf, Germany (ots/PRNewswire) - - Organic revenue growth of 3.1 % in core business - Strong development in High Value Solutions: Focus on Biological Solutions pays off - Adjusted EBITDA increases organically by 7.0 % in core business - Adjusted earnings per share rise organically by 29.3 % to EUR 0.57 - Guidance confirmed for the financial year 2021 "We got off to a good start in the financial year," said Dietmar ...

  • 08.04.2021 – 07:00

    Gerresheimer with positive start to the financial year 2021

    Duesseldorf (ots) - - Organic revenue growth of 3.1 % in core business - Strong development in High Value Solutions: Focus on Biological Solutions pays off - Adjusted EBITDA increases organically by 7.0 % in core business - Adjusted earnings per share rise organically by 29.3 % to EUR 0.57 - Guidance confirmed for the financial year 2021 "We got off to a ...

    One document
  • 18.02.2021 – 07:00

    Gerresheimer AG extends CEO Dietmar Siemssen’s contract by five years

    Duesseldorf (ots) - At its meeting yesterday, the Supervisory Board of Gerresheimer AG extended the contract with CEO Dietmar Siemssen (57) to the end of October 2026. Dietmar Siemssen has been CEO of Gerresheimer AG since November 2018. “Dietmar Siemssen has put Gerresheimer on the growth path. His ...

    One document
  • 18.02.2021 – 07:00

    Gerresheimer presents strong fourth quarter

    Duesseldorf (ots) - – Transformation in full swing: Continuous focus on growth delivers first positive results – Fourth-quarter Group revenues rise to 403m Euro: 7.3 % organic growth in the core business – Fourth-quarter adjusted EBITDA up to 100m Euro; 6.5 % organic growth in the core business – Target range for the financial year 2020 reached ...

    One document
  • 08.12.2020 – 15:15

    Gerresheimer: On the path to sustainable profitable growth

    Duesseldorf (ots) - - Transformation into a growth value as innovation leader and solution provider - Gerresheimer presents strategy process formula G as an engine towards sustainable profitable growth - Over proportional growth will be achieved by expanding in high value solutions, digital applications and growth regions - Strategic investments in growth ...

    One document
  • 13.10.2020 – 07:33

    Gerresheimer on track for strong second half-year

    Dusseldorf, Germany (ots/PRNewswire) - - Third quarter on schedule - Group revenues EUR 349m; 2.1% organic revenue growth in core business - Adjusted EBITDA increases by 4.1% to EUR 75m - Significant improvement in free cash flow to EUR 38m - Strong fourth quarter 2020 expected - Guidance for 2020 confirmed Gerresheimer AG delivered profitable growth in its core business in the third quarter of 2020 and confirmed its ...

  • 13.10.2020 – 07:01

    Gerresheimer on track for strong second half-year

    Dusseldorf (ots) - · Third quarter on schedule · Group revenues EUR 349m; 2.1% organic revenue growth in core business · Adjusted EBITDA increases by 4.1% to EUR 75m · Significant improvement in free cash flow to EUR 38m · Strong fourth quarter 2020 expected · Guidance for 2020 confirmed Gerresheimer AG delivered profitable growth in its core business ...

    One document
  • 14.07.2020 – 07:00

    Gerresheimer with strong second quarter

    Duesseldorf (ots) - - Implementation of growth strategy beginning to deliver results - Group revenues increase to EUR 363m with 4.6% organic growth in core business - 6.9% organic growth in adjusted EBITDA to EUR 84m - Impacts of pandemic under control; potential vaccination campaigns open opportunities for specialty glass vials - Revenue guidance for 2020 ...

    One document
  • 24.06.2020 – 16:44

    Annual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share

    Duesseldorf, Germany (ots/PRNewswire) - Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG. "In 2019, we paved the way for profitable growth and achieved a substantial improvement in the Company's culture and dynamic. We are investing and working to grow our innovation pipeline. These efforts continue ...

  • 16.06.2020 – 14:00

    Leading pharma packaging companies commit to supply for Covid-19 fight

    Düsseldorf (ots) - Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and ...

    One document
  • 09.04.2020 – 07:00

    Gerresheimer business model robust

    Duesseldorf (ots) - - Stable business model as key supplier to pharma and healthcare industry - Gerresheimer sustains growth path. Revenue guidance for 2020 in the mid single-digit percentage range and adjusted EBITDA margin of around 21% confirmed - Refinancing of EUR 190m promissory loan maturing in November 2020 secured ahead of time - First quarter level with prior year, as expected: revenues EUR 304m, ...

    One document
  • 19.02.2020 – 07:30

    Gerresheimer sets foundation for profitable growth in 2019

    Duesseldorf (ots) - -Foundation for sustainable and profitable growth laid in 2019: Annual revenue growth in the mid-single-digit percentage range targeted for 2020 and subsequent years -2019 operating targets met: Underlying revenues reach EUR 1.40bn and underlying adjusted EBITDA EUR 293m -Further increase in proposed dividend to EUR 1.20 per share from ...

    One document
  • 19.11.2019 – 13:38

    New Focus in Project Portfolio of Gerresheimer Subsidiary Sensile Medical

    Dusseldorf, Germany (ots/PRNewswire) - - SQ Innovation and Gerresheimer sign partnership for micro pumps for heart failure treatment - Sanofi terminates development project for micro pumps for patients with diabetes - Further projects with pharma customers for various therapy areas for the micro pump started Sensile Medical, a subsidiary of Gerresheimer AG, has signed ...

  • 19.11.2019 – 12:00

    New focus in project portfolio of Gerresheimer subsidiary Sensile Medical

    Duesseldorf (ots) - - SQ Innovation and Gerresheimer sign partnership for micro pumps for heart failure treatment - Sanofi terminates development project for micro pumps for patients with diabetes - Further projects with pharma customers for various therapy areas for the micro pump started Sensile Medical, a subsidiary of Gerresheimer AG, has signed a contract with the ...

  • 10.10.2019 – 08:33

    Gerresheimer advances growth and technology projects in third quarter

    Düsseldorf (ots) - - Revenues up 1.4 % on the prior-year quarter to EUR 358.6m - Adjusted EBITDA at EUR 72.2m in third quarter of 2019 - Adjusted net income at EUR 30.7m in third quarter of 2019 - New innovation center for pharmaceutical glass opened in the US - Successful refinancing by a EUR 550.0m ...

    One document